Antithyroid drug-induced aplastic anemia

Thyroid

Volumn 18, Issue 10, 2008, Pages 1043-1048

  Thomas, Dimitrios ^a   Moisidis, Anestis ^a   Tsiakalos, Aristotelis ^a   Alexandraki, Krystallenia ^a   Syriou, Vassiliki ^a   Kaltsas, Gregory ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTITHYROID AGENT; CARBIMAZOLE; CYCLOSPORIN; FILGASTRIME; GRANULOCYTE ANTIBODY; LUGOL; PREDNISOLONE; PROPRANOLOL; PROPYLTHIOURACIL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THIAMAZOLE; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; VORICONAZOLE;

ADULT; AGRANULOCYTOSIS; APLASTIC ANEMIA; ARTICLE; BONE MARROW APLASIA; CASE REPORT; CONCURRENT INFECTION; CONVALESCENCE; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GRANULOCYTE; GRAVES DISEASE; HEMATOPOIETIC STEM CELL; HUMAN; HUMORAL IMMUNITY; HYPERTHYROIDISM; MONOCYTE; MORTALITY; MYELOID PROGENITOR CELL; PATHOGENESIS; PLASMACYTOSIS; PRIORITY JOURNAL; PROGNOSIS; THYROID FUNCTION TEST; THYROIDECTOMY;

ADULT; AGRANULOCYTOSIS; ANEMIA, APLASTIC; ANTITHYROID AGENTS; CARBIMAZOLE; FEMALE; GRAVES DISEASE; HUMANS; KAPLAN-MEIERS ESTIMATE; METHIMAZOLE; MIDDLE AGED;

EID: 53649091184     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2008.0097     Document Type: Article

References (38)

1. Tunbridge WMG, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA 1997 The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol 7:483-493.
2. Weetman AP 2000 Graves' disease. N Engl J Med 343:1236-1248.
3. Cooper DS 2005 Antithyroid drugs. New Engl J Med 352:905-917.
4. Tajiri J, Noguchi S 2004 Antithyroid drug-induced agranulocytosis: special reference to normal white blood cell count agranulocytosis. Thyroid 14:459-462.
5. Yamamoto A, Katayama Y, Tomiyama K, Hosoai H, Hirata F, Kimura F, Fujita K, Yasuda H 2004 Methimazole-induced aplastic anemia caused by hypocellular bone marrow with plasmacytosis. Thyroid 14:231-235.
6. Pearce SHS 2004 Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK. Clin Endocrinol 61:589-594.
7. International Agranulocytosis and Aplastic anemia study 1988 Risk of agranulocytosis and aplastic anemia in relation to use of antithyroid drugs. BMJ 297:262-265.
8. Fukata S, Kuma K, Sugawara M 1999 Granulocyte colony-stimulating factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: a prospective study. Thyroid 9:29-31.
9. Andres E, Kurtz JE, Perrin AE, Dufour P, Schlienger JL, Maloisel F 2001 Haematopoietic growth factor in antithyroid-drug-induced agranoulocytosis. Q J Med 94:423-428.
10. Tamai H, Mukuta T, Matsubayashi S, Fukata S, Komaki G, Kuma K, Kumagai F, Nagataki S 1993 Treatment of methimazole-induced agranulocytosis using recombinant human granulocyte colony-stimulating factor (rhG-CSF). J Clin Endocrinol Metab 77:1356-1360.
11. Breier DV, Rendo P, Gonzalez J, Shilton G, Stivel M, Goldztein S 2001 Massive plasmocytosis due to methimazole-induced bone marrow toxicity. Am J Hematol 67:259-261.
12. Mechelli S, Bolognesi S, Siuti E, Stefanelli A, Catiglioni MG 1999 Methimazole-induced aplastic anemia. Recenti Prog Med 90:470-472.
13. Mezquita P, Luna V, Munoz-Torres M, Torres-Vela E, Lopez-Rodriguez F, Callejas JL, Escobar-Jimenez F 1998 Methimazole-induced aplastic anemia in third exposure: successful treatment with recombinant human granulocyte colony-stimulating factor. Thyroid 8:791-794.
14. Jacuks J, Pocsay G 2006 Successful treatment of methimazole-induced severe aplastic anemia with recombinant human granulocyte colony-stimulating factor and high-dosage steroids. J Endocrinol Invest 29:74-77.
15. Escobar-Morreale HF, Bravo P, Garcia-Robles R, Garcia-Larana J, de la Calle H, Sancho JM 1997 Methimazole-induced severe aplastic anemia: unsuccessful treatment with recombinant human granulocyte-monocyte colony-stimulating factor. Thyroid 7:67-70.
16. Undas A, Dreger B, Skaluba Z, Musial J 1998 Bone marrow aplasia and liver damage caused by methimazole. Pol Arch Med Wewn 99:493-496.
17. Swider G, Grzywa M, Zuzak Z 1996 Severe aplastic anemia as a complication of treatment with metizol. Wiad Lek 49:136-139.
18. Lopez-Karpovitch X, Ulloa-Aquirre A, von Eiff C, Hurtado-Monroy R, Alanis A 1992 Treatment of methimazole-induced severe aplastic anemia with recombinant human granulocyte-monocyte colony-stimulating factor and glucocorticosteroids. Acta Hematol 87:148-150.
19. Kobayashi T, Ishiguro A, Andoh O, Tsuji K, Naganuma K, Yagi Y, Nakahata T, Akabane T 1987 A case of drug (methimazole)-induced secondary aplastic anemia. Rinsho Ketsueki 28:1587-1592.
20. Milosevic R, Bogunovic M, Antonijevic N 2004 Aplastic anemia caused by thiamazole-a case report. Srp Arh Celok Lek 132:171-173.
21. Biswas N, Ahn YH, Goldman JM, Schwartz JM 1991 Aplastic anemia associated with antithyroid drugs. Am J Med Sci 301:190-194.
22. Aksoy M, Erdem S 1968 Aplastic anemia after propylthiouracil. Lancet 291:1379.
23. Martelo OJ, Katims RB, Yunis AA 1967 Bone marrow aplasia following propylthiouracil therapy. Report of a case with complete recovery. Arch Intern Med 120:587-590.
24. Wilcox J, Wong R, Elliott PJ, Topliss DJ, Stockigt JR 2003 Recovery from carbimazole induced aplastic anemia. Inter J Endocrinol Metab 1:41-43.
25. Tajiri J, Noguchi S 2005 Antithyroid drug-induced agranulocytosis: how has granulocyte colony-stimulating factor changed therapy? Thyroid 15:292-297.
26. Dai WX, Zhang JD, Zhan SW, Xu BZ, Jin H, Yao Y, Xin WC, Bai Y 2002 Retrospective analysis of 18 cases of antithyroid drug (ATD)-induced agranulocytosis. Endocr J 49:29-33.
27. Huang CH, Li KI, Wu JH, Wang PN, Juang JH 2007 Antithyroid drug-induced agranulocytosis: report of 13 cases. Chang Gung Med J 30:242-248.
28. Tamai H, Mukuta T, Matsubayashi S, Fukata S, Komaki G, Kuma K, Kumagai LF, Nagataki S 1993 Treatment of methimazole-induced agranulocytosis using human granulocyte colony-stimulating factor (rh-CSF). J Clin Endocrinol Metab 77:1356-1360.
29. Tsuboi K, Ueshiba H, Shimojo M, Ishikawa M, Watanabe M, Nagasawa K, Yuasa E, Yoshino G 2007 The relation of initial methimazole dose to the incidence of methimazole induced agranulocytosis in patients with Graves' disease. Endocr J 54:39-43.
30. Cooper DS 1998 Antithyroid drugs for the treatment of hyperthyroidism caused by Graves' disease. Endocrinol Metab Clin North Am 27:225-47.
31. Tajiri J, Noguchi S, Murakami N 1997 Usefulness of granulocyte count measurement four hours after injection of granulocyte colony-stimulating factor for detecting recovery from antithyroid drug-induced granulocytopenia. Thyroid 7:575-578.
32. Moreb J, Shemesh O, Shilo S, Manor C, Hershko C 1983 Transient methimazole-induced bone marrow aplasia: in vitro evidence for a humoral mechanism of bone marrow suppression. Acta Hematol 69:127-131.
33. Berkman EM, Orlin JB, Wolfsdorf J 1983 An anti-neutrophil antibody associated with a propylthiouracil-induced lupus-like syndrome. Transfusion 23:135-138.
34. Fibbe WE, Claas FHJ, Van der Star-Dijkstra W, Schaafsma MR, Mayboom RH, Falkenburg JH 1986 Agranulocytosis induced by propylthiouracil: evidence of a drug dependent antibody reacting with granulocytes, monocytes, and haematopoietic progenitor cells. Br J Haematol 64:363-373.
35. Edell SL, Bartuska DG 1975 Aplastic anemia secondary to methimazole-case report and review of hematologic side effects. J Am Med Womens Ass 30:412-413.
36. Young NS, Calado RT, Scheinberg P 2006 Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 108:2509-2519.
37. Sheng WH, Hung GG, Chen YC, Fang CT, Hsieh SM, Chang SC, Hsieh WC 1999 Antithyroid-drug-induced agranulocytosis complicated by life threatening infections. Q J Med 92:455-461.
38. Meyer-Gressner M, Benker G, Lederbogen S, Olbricht T, Reinwein D 1993 Antithyroid drug-induced agranulocytosis: clinical experience with ten patients treated at one institution and review of the literature. J Endocrinol Invest 17:29-36.